Page 21 - Beckley Psytech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The portrait taken with her pigeon Birdie just after the procedure In 1970, Amanda Feilding caused a furore after drilling a hole into her own skull (yes, really!). After decades of being dismissed as an oddball, her belief in the benefits of psychedelic drugs is suddenly being taken seriously   'I am not really in love with ketamine,’ states Amanda Feilding, the Countess of Wemyss and March. It’s a rather startling revelation for a 78-year-old woman of impeccable manners who looks as though her field of expertise may be some finer point of social etiquette. But Amanda has never been a ...

This article by Jennifer Walker-Journey was originally published on Psychedelic Spotlight, and appears here with permission. United Kingdom-based startup Beckley Psytech is gearing up for a Phase 1 clinical trial investigating a synthetic version of 5-MeO-DMT. The trial is looking at the benefits of this unique psychedelic as a treatment of neuropsychiatric diseases.  5-MeO-DMT is an unlikely psychedelic compound. It’s not a plant or fungus — it’s excreted through the skin of the Sonoran Desert toad. Chemically similar to DMT, 5-MeO-DMT is fast-acting with a short duration. Researc...

California’s legislature could soon be discussing a new bill meant to decriminalize psychedelic substances. On Tuesday, State Senator Scott Wiener announced via Twitter his intention to introduce a new bill aimed at pulling back on penalties for the non-commercial use of these drugs, first... Read More... Don't Miss Any Updates! News Directly in Your Inbox Subscribe to:

Woman has suffered a non-stop headache for eight years Rebecca McDonough's headache first struck like 'an electric shock' in 2012 Rebecca in 2013 (Image: PA REAL LIFE) There are always big stories on WalesOnline - don't miss any with our daily emailInvalid EmailSomething went wrong, please try again later. Sign me up now When you subscribe we will use the information you provide to send you these newsletters. Your information will be used in accordance with ourPrivacy Notice. Thank you for subscribingWe have more newslettersShow meSee ourprivacy notice A woman who has suffered a constant head...

Noetic Fund II LP: Noetic Launches Second Fund to Invest in Emergent Psychedelic Medicine Sector Having successfully launched one of the first funds operating in the nascent psychedelic medicine space, Toronto-based venture capital firm Noetic is now launching a second, larger Fund. TORONTO, ON / ACCESSWIRE / March 4, 2021 / The "Noetic Funds," founded by the team at Grey House Partners GP Inc., has announced the launch of Noetic Fund II LP ("Fund II"), a venture capital fund that is seeking to raise a minimum of $200mm to invest in early-stage psychedelic and Central Nervous System focused c...